We understand that your SOPs, genetics knowledge, and brand are your most valuable assets. Sharing them with foreign partners without bulletproof protection is a non-starter. Here's how we handle it:
Staged disclosure model. No sensitive information is shared before a binding agreement is signed. Stage 1 (Market Analysis) requires zero IP from you. Stage 2 involves high-level brand and product discussions under NDA. Stage 3 transfers specific SOPs only after the licensing agreement is executed.
Contractual protection. All partnership agreements include non-compete clauses, usage restrictions, quality mandates, and termination rights. Contracts are governed by German law with international arbitration options. We work with German IP attorneys who specialize in cross-border licensing.
Practical protection. SOPs are transferred in modular form — partners receive what they need to execute, not your entire playbook. Core proprietary methods can be retained and delivered through ongoing consulting rather than documentation. Training is conducted by resolyze, not by sharing raw documents.
What we cannot guarantee: German association law is new and evolving. The KCanG has been in effect since April 2024. Case law is limited. We design contracts based on current best practices and update them as the regulatory landscape develops. We're transparent about what's tested and what's new — because that's the only way to build trust.